Objective: To conduct a cost-effectiveness analysis comparing behavioral health integration (BHI) in primary care vs clinical decision support (usual care) for adult pat ...
Last month, the Institute for Clinical and Economic Review (ICER) issued a draft report on the cost-effectiveness of bluebird bio’s lovo-cel (lovotibeglogene autotemcel) and Vertex/CRISPR’s ...
Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results